CA2252116A1 - N-3 substituted pyrimidin-4-ones with aii antagonistic activity - Google Patents

N-3 substituted pyrimidin-4-ones with aii antagonistic activity Download PDF

Info

Publication number
CA2252116A1
CA2252116A1 CA002252116A CA2252116A CA2252116A1 CA 2252116 A1 CA2252116 A1 CA 2252116A1 CA 002252116 A CA002252116 A CA 002252116A CA 2252116 A CA2252116 A CA 2252116A CA 2252116 A1 CA2252116 A1 CA 2252116A1
Authority
CA
Canada
Prior art keywords
methyl
group
tetrazol
butyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002252116A
Other languages
English (en)
French (fr)
Inventor
Davide Poma
Renato Canevotti
Aldo Salimbeni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Luso Farmaco dItalia SpA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2252116A1 publication Critical patent/CA2252116A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002252116A 1996-04-19 1997-04-11 N-3 substituted pyrimidin-4-ones with aii antagonistic activity Abandoned CA2252116A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI96A000756 1996-04-19
IT96MI000756A IT1283620B1 (it) 1996-04-19 1996-04-19 "pirimidin-4-oni n-3 sostituiti ad attivita' aii antagonista"

Publications (1)

Publication Number Publication Date
CA2252116A1 true CA2252116A1 (en) 1997-10-30

Family

ID=11374028

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002252116A Abandoned CA2252116A1 (en) 1996-04-19 1997-04-11 N-3 substituted pyrimidin-4-ones with aii antagonistic activity

Country Status (7)

Country Link
US (1) US6096754A (forum.php)
EP (1) EP0900215A1 (forum.php)
CN (1) CN1216541A (forum.php)
AU (1) AU2384897A (forum.php)
CA (1) CA2252116A1 (forum.php)
IT (1) IT1283620B1 (forum.php)
WO (1) WO1997040040A1 (forum.php)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2002837A1 (en) 1998-07-06 2008-12-17 Bristol-Myers Squibb Company Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE912114A1 (en) * 1990-07-02 1992-01-15 Union Pharma Scient Appl Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present
IT1250749B (it) * 1991-08-02 1995-04-21 Luso Farmaco Inst Composti eterociclici ad attivita' a ii antagonista

Also Published As

Publication number Publication date
ITMI960756A1 (it) 1997-10-19
CN1216541A (zh) 1999-05-12
ITMI960756A0 (forum.php) 1996-04-19
WO1997040040A1 (en) 1997-10-30
IT1283620B1 (it) 1998-04-22
AU2384897A (en) 1997-11-12
US6096754A (en) 2000-08-01
EP0900215A1 (en) 1999-03-10

Similar Documents

Publication Publication Date Title
CA2037630C (en) Nitrogen-containing heterocylic compounds, their production and use
DE69233113T2 (de) Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung
DE69123784T2 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und Anwendung
EP0443568B1 (en) Fused thiophene derivatives, their production and use
US5474996A (en) Pyrimidine derivatives
EP0434038A1 (en) Fused imidazole derivatives, their production and use
IE82833B1 (en) Pharmaceutical compositions comprising angiotensin ii receptor blocking imidazoles and diuretics
JPH069572A (ja) ビフェニルスルホニル尿素またはビフェニルスルホニルウレタン側鎖を有するイミダゾール誘導体、その製法およびその使用
LV12047B (en) CONDENSED PIRIMIDINE DERIVATIVES AND THEIR USE OF ANGIOTENZINE II ANTAGONISTS
HUT70485A (en) Substituted mono- and bipyridyl-methyl-pyridone derivatives and process for producing them
EP0654030B1 (en) Imidazole derivatives having angiotensin ii antagonist activity
SK10694A3 (en) Compounds having angiotensine ii antagonistic activity
JP2000517329A (ja) アジニルオキシ―ジアリール―カルボン酸誘導体及びフェノキシ―ジアリール―カルボン酸誘導体、それらの製法及び混合ｅｔａ／ｅｔｂ―エンドセリン受容体拮抗剤としての使用
JP2005529843A (ja) トリアゾロ［４，３−ａ］ピリド［２，３−ｄ］ピリミジン−５−オン、それらを含有する組成物、その製造方法及び使用
US5500427A (en) Cyclic compounds and their use
HUT62576A (en) Process for producing substituted imidazolylpropenoic acid derivatives and pharmaceutical compositions comprising such compounds
HUT62578A (en) Process for producing cyclic group-substituted imidazolylpropenoic acid derivatives and pharmaceutical compositions comprising such compounds
JP2529798B2 (ja) ４−ピリミジノン誘導体、その製造方法および治療への適用
US5284661A (en) Fused thiophene derivatives, their production and use
JPH05186462A (ja) 複素環式化合物、その製造方法および該化合物を含有する高血圧症およびうつ血性心麻痺用の医薬調剤
CA2252116A1 (en) N-3 substituted pyrimidin-4-ones with aii antagonistic activity
EP1586572A1 (en) Fused pyrazolyls as anti-cancer drugs
KR19980701690A (ko) 엔도텔린 길항제로서의 치환 페닐 화합물
DK153485B (da) Analogifremgangsmaade til fremstilling af pyridopyrimidinderivater
JPH0625250A (ja) チエノ〔３，４−ｄ〕イミダゾール誘導体、その製造法およびそれを含有する循環器官用剤

Legal Events

Date Code Title Description
FZDE Discontinued